Drug discovery is often imagined as a race toward entirely new molecules, but some of the most promising breakthroughs begin by looking again at what we already know. This session explores the logic and potential of drug rediscovery: how existing compounds can be re-examined, repurposed, and developed into new therapeutic opportunities more efficiently and strategically. Are you interested in biotech translation, and entrepreneurship? Then this is the talk for you.
- Others
